Pricing Log in Create free account

Fulcrum Therapeutics, Inc. (FULC) vs Century Therapeutics, Inc. (IPSC)

Fulcrum Therapeutics, Inc. and Century Therapeutics, Inc. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and Century Therapeutics, Inc. are of similar size ($280.0M and $271.6M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against 1,939.8%. Across the 12 metrics below, Fulcrum Therapeutics, Inc. leads on 9 and Century Therapeutics, Inc. on 3.

Valuation

Metric FULC IPSC Biotechnology median
P/E n/m n/m 8.50
P/S 3.37 2.45 9.71
P/B 0.90 1.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.43 n/m 0.64
EV/Sales (0.49) 1.41 9.21
Earnings yield (33.15%) (67.88%) (33.15%)
Free cash flow yield (23.60%) (31.23%) (25.50%)

Profitability

Metric FULC IPSC Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (32.38%) (49.65%) (56.36%)
Return on assets (30.75%) (38.41%) (48.04%)
Return on invested capital 0.00% (64.92%) 0.00%

Growth

Metric FULC IPSC Biotechnology median
Revenue growth (TTM) 1,939.80% 8,286.72% 6.02%
EPS growth (last fiscal year) (637.50%) 93.12% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FULC IPSC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.35 8.28 4.72
Net debt to EBITDA 4.23 17.95 0.96

Dividend

Metric FULC IPSC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FULC IPSC Biotechnology median
Market cap 280.01m 271.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack